Liver fibrosis, host genetic and hepatitis C virus related parameters as predictive factors of response to therapy against hepatitis C virus in HIV/HCV coinfected patients.

OBJECTIVE: To establish the role of liver fibrosis as a predictive tool of response to pegylated interferon alpha (Peg-IFN) and ribavirin (RBV) treatment in human immunodeficiency (HIV)/hepatitis C virus (HCV) coinfected patients, in addition to recognized predictive factors (HCV load, HCV genotype,...

Full description

Bibliographic Details
Main Authors: Sara Corchado, Luis F López-Cortés, Antonio Rivero-Juárez, Almudena Torres-Cornejo, Antonio Rivero, Mercedes Márquez-Coello, José-Antonio Girón-González
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4094489?pdf=render